CBS TODAY Healthwatch 23andMe CEO Anne Wojcicki talks genetic examining.

It could mean parents would be able to pick their children predicated on genetic superiority, what critics known as ‘designer babies.’ The company later on clarified that while at that time they filed the patent they were considering practical applications in the fertility clinic, they possess since decided to go in a different direction.. 23andMe will no longer provide health-related genetics data Genetic testing company 23andMe said Thursday it will still allow consumers to gain access to ancestry-related information and raw genetic data without interpretation while complying with a Food and Drug Administration regulatory review.The companies mentioned above offering fake peer reviews all come from countries and China in Southeast Asia, & most of the authors involved with these full cases result from the same areas. But it will be a mistake to look at this simply because a Asian or Chinese issue. The problem is the perverse incentive systems in scientific publishing. Provided that authors are rewarded for publishing many content articles and editors are rewarded for publishing them rapidly, new ways of gaming the original publication versions will be invented more quickly than new control procedures could be put in place. If there’s a subject you would like to see, leave an indicator in the remarks section or send us a tweet at @CBSEveningNews.